U

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

Technical & Interface Coordinator Beltech

Mechanical Maintenance and Reliability EngineeringUpdated on Nov 14
Full-timeBraine-l'Alleud, BelgiumNo salary listed

About the Job

Requirements

  • A Bachelor’s or Master’s degree in Engineering, Automation, Utilities, or a related field is required.
  • Strong experience in good manufacturing practice, pharmaceutical, or highly regulated industrial environments is required.
  • Knowledge of automation systems, industrial networks, and technical equipment is required.
  • Experience with computerized maintenance management system tools, SAP processes, qualification, and validation activities is required.
  • Effective communication skills in both French and English are required.
  • An analytical mindset and the ability to influence and collaborate across functions are required.

Responsibilities

  • Gather and formalize maintenance requirements from operational teams.
  • Translate operational needs into technical specifications for engineering projects.
  • Participate in design reviews and technical clarification meetings.
  • Monitor emerging technologies, standards, and innovative technical solutions.
  • Support commissioning activities, maintenance handovers, and technical training.
  • Ensure maintenance requirements are integrated into design, qualification, and project delivery phases.
  • Act as the key technical interface between Maintenance and Engineering teams across UCB’s Belgian sites, ensuring operational needs and maintainability requirements are embedded into investment and continuous improvement projects.
  • Help drive technology adoption, improve asset reliability, and support effective project transitions into operational maintenance.
  • Collaborate with Project Managers to ensure maintenance requirements are considered throughout project design, qualification, commissioning, and handover activities.

About the Company

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

UCB Pharma focuses on developing treatments for severe diseases in neurology and immunology. It discovers, develops, and commercializes novel molecules and generates products aimed at improving patient lives. The company works by researching and developing therapies, integrating patient insights to guide innovation, and investing over a quarter of revenue into scientific research. Its global presence (about 9,000 employees across 40 countries) and €5.3 billion 2023 revenue reflect its scale and commitment to bringing therapies to patients worldwide. UCB differentiates itself by combining direct patient engagement with substantial R&D investment to address unmet needs in neurology and immunology, aiming to transform lives through science and patient care.

Company size
10,001+
Company stage
IPO
Headquarters
City of Brussels, Belgium
Founded
1928

Recently Posted Jobs

Explore more opportunities at UCB Pharma

See more jobs